Press coverage about RTI Surgical (NASDAQ:RTIX) has been trending somewhat positive recently, Accern reports. The research firm rates the sentiment of media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. RTI Surgical earned a media sentiment score of 0.05 on Accern’s scale. Accern also gave news coverage about the medical equipment provider an impact score of 46.0278859673967 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

RTI Surgical (NASDAQ:RTIX) traded up 1.10% on Wednesday, hitting $4.60. The company’s stock had a trading volume of 76,729 shares. RTI Surgical has a 1-year low of $2.50 and a 1-year high of $6.00. The company’s market capitalization is $271.56 million. The company has a 50 day moving average price of $5.09 and a 200-day moving average price of $4.68.

RTI Surgical (NASDAQ:RTIX) last posted its earnings results on Tuesday, August 8th. The medical equipment provider reported $0.02 EPS for the quarter, meeting analysts’ consensus estimates of $0.02. The firm had revenue of $72.10 million during the quarter, compared to the consensus estimate of $70.25 million. RTI Surgical had a positive return on equity of 2.07% and a negative net margin of 6.53%. The firm’s quarterly revenue was up 6.7% compared to the same quarter last year. On average, equities analysts forecast that RTI Surgical will post $0.06 earnings per share for the current fiscal year.

Several research analysts have issued reports on the company. BidaskClub cut RTI Surgical from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 25th. Zacks Investment Research raised RTI Surgical from a “hold” rating to a “buy” rating and set a $6.25 price target on the stock in a report on Wednesday, June 28th. Finally, ValuEngine raised RTI Surgical from a “sell” rating to a “hold” rating in a report on Friday, June 2nd.

COPYRIGHT VIOLATION WARNING: “RTI Surgical (RTIX) Earning Somewhat Favorable Media Coverage, Analysis Shows” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright & trademark law. The original version of this story can be accessed at https://www.thecerbatgem.com/2017/09/06/rti-surgical-rtix-earning-somewhat-favorable-media-coverage-analysis-shows.html.

In other news, Director Nicholas J. Valeriani acquired 5,500 shares of the business’s stock in a transaction that occurred on Monday, August 21st. The shares were purchased at an average price of $4.70 per share, for a total transaction of $25,850.00. Following the acquisition, the director now owns 47,754 shares of the company’s stock, valued at $224,443.80. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP John N. Varela acquired 12,000 shares of the business’s stock in a transaction that occurred on Friday, August 11th. The stock was purchased at an average price of $4.85 per share, for a total transaction of $58,200.00. Following the acquisition, the executive vice president now directly owns 47,998 shares in the company, valued at approximately $232,790.30. The disclosure for this purchase can be found here. Corporate insiders own 4.90% of the company’s stock.

RTI Surgical Company Profile

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Insider Buying and Selling by Quarter for RTI Surgical (NASDAQ:RTIX)

Receive News & Stock Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related stocks with our FREE daily email newsletter.